EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Utilizing Nanoparticles to Overcome Anti-PD-1/PD-L1 Immunotherapy Resistance in Non-Small Cell Lung cancer: A Potential Strategy

Yuli Ge iD, Qiong Zhou, Fan Pan, Rui Wang

International Journal of Nanomedicine · 2025

DOI: 10.2147/ijn.s505539 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Yuli Ge und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Jinling Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, People's Republic…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Immune Checkpoint Inhibitors, Nanoparticles. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 204 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsImmune Checkpoint InhibitorsNanoparticlesDrug Resistance, NeoplasmHumansTumor MicroenvironmentImmunotherapyAnimalsB7-H1 AntigenProgrammed Cell Death 1 Receptor

Stichwörter der Autor:innen

PD-1/PD-L1immunosuppression TMEimmunotherapynanoparticlespro-inflammatory TMEresistance mechanisms

Substanzen

Immune Checkpoint InhibitorsB7-H1 AntigenProgrammed Cell Death 1 ReceptorCD274 protein, humanPDCD1 protein, human

Autor:innen und Institutionen

  • Department of Medical Oncology, Jinling Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, People's Republic of China.
  • Department of Medical Oncology, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, 210093, People's Republic of China.

ORCID-Profile: Yuli Ge

Zitieren

APA

Ge, Y., Zhou, Q., Pan, F., & Wang, R. (2025). Utilizing Nanoparticles to Overcome Anti-PD-1/PD-L1 Immunotherapy Resistance in Non-Small Cell Lung cancer: A Potential Strategy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s505539

Vancouver

Ge Y, Zhou Q, Pan F, Wang R. Utilizing Nanoparticles to Overcome Anti-PD-1/PD-L1 Immunotherapy Resistance in Non-Small Cell Lung cancer: A Potential Strategy. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s505539

BibTeX
@article{Ge2025,
  author = {Ge, Yuli and Zhou, Qiong and Pan, Fan and Wang, Rui},
  title = {Utilizing Nanoparticles to Overcome Anti-PD-1/PD-L1 Immunotherapy Resistance in Non-Small Cell Lung cancer: A Potential Strategy},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  doi = {10.2147/ijn.s505539}
}
Kostenlos starten →